Market Overview:
The global pelvic organ prolapse devices market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of pelvic organ prolapse, rising awareness about the available treatment options, and technological advancements in pelvic organ prolapse devices. Based on type, the global pelvic organ prolapse devices market is segmented into vaginal pessary and vaginal mesh. The vaginal mesh segment is expected to grow at a higher CAGR than the vaginal pessary segment during the forecast period. This growth can be attributed to the increasing use of surgical meshes for treating severe forms of pelvic organ prolapse. Based on application, the global pelvic organ prolapse devices market is divided into mild Pelvic Organ Prolapsed (POP), stress urinary incontinence (SUI), and severe Pelvic Organ Prolapsed (POP). The severe POP segment accounts for a larger share of the global market than other segments due to high incidence rate of this condition and availability of advanced treatment options such as surgical meshes.
Product Definition:
A pelvic organ prolapse device is a medical device that is used to treat pelvic organ prolapse. Pelvic organ prolapse devices are important because they can help to restore the function of the pelvic organs and improve the quality of life for women who suffer from this condition.
Vaginal Pessary:
A vaginal pessary is a device used to support the uterus in women who have suffered from pelvic organ prolapse. It is also known as artificial vagina, woman's friend or wisp. Vaginal pessaries are widely used for treating prolapse of the uterus and may be used in combination with other treatments such as hysterectomy or surgical repair.
Vaginal Mesh:
A vaginal mesh is a type of surgical reconstruction device used to reinforce or restore the tissues of the pelvic floor. It is most commonly used for treating prolapse, which is caused by weakened or lose supporting tissues due to age, obesity, and childbirth (obstructive prolapse). Prolapse can also occur as a result of disease such as cancer.
U.
Application Insights:
Mild pelvic organ prolapse is expected to be the fastest-growing application segment over the forecast period owing to increasing awareness about health and wellness. Moreover, growing geriatric population in countries such as Germany and Japan is expected to increase the demand for minimally invasive surgeries, thereby supporting market growth.
Stress urinary incontinence is anticipated to be one of the significant applications owing to increasing cases of stress urinary incontinence (SUI) globally. According with a study published by NCBI in 2018, it was found that around 60% women suffer from SUI at least once during their life span. The condition can also lead into more severe forms such as urge incontinence and chronic bladder pain syndrome (CBP). Increasing number of patients suffering from SUI has led healthcare providers worldwide towards developing new treatment options for this condition which will eventually support market growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017 owing to a high prevalence of vaginal mesh related disorders, rising awareness about these products and availability of highly skilled physicians. In addition, increasing R&D activities by various companies for development of novel devices is also expected to drive growth during the forecast period.
Asia Pacific is expected to grow at a lucrative rate over the forecast period due to factors such as improving healthcare infrastructure and growing medical tourism industry in emerging economies such as India, China & Japan. Moreover, an increase in number of surgeries due to rise in incidence will boost demand further. For instance; according Pelvic Organ Prolapse Society (POPS), Inc.
In 2016 Urogynecology was recognized by WHO as a specialty within International Continence Society (ICS).
Growth Factors:
- Increasing incidence of pelvic organ prolapse (POP) due to changing lifestyle and increasing aging population.
- Growing awareness about the symptoms and treatment options for POP.
- Rising demand for minimally invasive procedures for the treatment of POP.
- Technological advancements in pelvic organ prolapse devices market leading to introduction of new products and procedures.
- Growing number of private clinics offering pelvic organ prolapse devices treatments
Scope Of The Report
Report Attributes
Report Details
Report Title
Pelvic Organ Prolapse Devices Market Research Report
By Type
Vaginal Pessary, Vaginal Mesh
By Application
Mild Pelvic Organ Prolapse, Stress Urinary Incontinence, Severe Pelvic Organ Prolapse
By Companies
CooperSurgical, MedGyn, Personal Medical Corp, Integra LifeSciences, Panpac Medical, Medesign, Smiths Medical, Thomas Medical, Kangge Medical, Dr. Arabin, CooperSurgical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
169
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Pelvic Organ Prolapse Devices Market Report Segments:
The global Pelvic Organ Prolapse Devices market is segmented on the basis of:
Types
Vaginal Pessary, Vaginal Mesh
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Mild Pelvic Organ Prolapse, Stress Urinary Incontinence, Severe Pelvic Organ Prolapse
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CooperSurgical
- MedGyn
- Personal Medical Corp
- Integra LifeSciences
- Panpac Medical
- Medesign
- Smiths Medical
- Thomas Medical
- Kangge Medical
- Dr. Arabin
- CooperSurgical
Highlights of The Pelvic Organ Prolapse Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Vaginal Pessary
- Vaginal Mesh
- By Application:
- Mild Pelvic Organ Prolapse
- Stress Urinary Incontinence
- Severe Pelvic Organ Prolapse
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pelvic Organ Prolapse Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pelvic organ prolapse devices are a type of surgical intervention that is used to treat pelvic floor dysfunction. These devices help support and maintain the pelvic floor muscles, which can become weak or lose their ability to keep the bladder and bowel in place. Pelvic organ prolapse devices may also be used to correct other symptoms associated with pelvic floor dysfunction, such as incontinence or sexual dysfunction.
Some of the major companies in the pelvic organ prolapse devices market are CooperSurgical, MedGyn, Personal Medical Corp, Integra LifeSciences, Panpac Medical, Medesign, Smiths Medical, Thomas Medical, Kangge Medical, Dr. Arabin, CooperSurgical.
The pelvic organ prolapse devices market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pelvic Organ Prolapse Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pelvic Organ Prolapse Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pelvic Organ Prolapse Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pelvic Organ Prolapse Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pelvic Organ Prolapse Devices Market Size & Forecast, 2018-2028
4.5.1 Pelvic Organ Prolapse Devices Market Size and Y-o-Y Growth
4.5.2 Pelvic Organ Prolapse Devices Market Absolute $ Opportunity
Chapter 5 Global Pelvic Organ Prolapse Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pelvic Organ Prolapse Devices Market Size Forecast by Type
5.2.1 Vaginal Pessary
5.2.2 Vaginal Mesh
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pelvic Organ Prolapse Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pelvic Organ Prolapse Devices Market Size Forecast by Applications
6.2.1 Mild Pelvic Organ Prolapse
6.2.2 Stress Urinary Incontinence
6.2.3 Severe Pelvic Organ Prolapse
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pelvic Organ Prolapse Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pelvic Organ Prolapse Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pelvic Organ Prolapse Devices Analysis and Forecast
9.1 Introduction
9.2 North America Pelvic Organ Prolapse Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pelvic Organ Prolapse Devices Market Size Forecast by Type
9.6.1 Vaginal Pessary
9.6.2 Vaginal Mesh
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pelvic Organ Prolapse Devices Market Size Forecast by Applications
9.10.1 Mild Pelvic Organ Prolapse
9.10.2 Stress Urinary Incontinence
9.10.3 Severe Pelvic Organ Prolapse
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pelvic Organ Prolapse Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Pelvic Organ Prolapse Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pelvic Organ Prolapse Devices Market Size Forecast by Type
10.6.1 Vaginal Pessary
10.6.2 Vaginal Mesh
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pelvic Organ Prolapse Devices Market Size Forecast by Applications
10.10.1 Mild Pelvic Organ Prolapse
10.10.2 Stress Urinary Incontinence
10.10.3 Severe Pelvic Organ Prolapse
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pelvic Organ Prolapse Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pelvic Organ Prolapse Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pelvic Organ Prolapse Devices Market Size Forecast by Type
11.6.1 Vaginal Pessary
11.6.2 Vaginal Mesh
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pelvic Organ Prolapse Devices Market Size Forecast by Applications
11.10.1 Mild Pelvic Organ Prolapse
11.10.2 Stress Urinary Incontinence
11.10.3 Severe Pelvic Organ Prolapse
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pelvic Organ Prolapse Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Pelvic Organ Prolapse Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pelvic Organ Prolapse Devices Market Size Forecast by Type
12.6.1 Vaginal Pessary
12.6.2 Vaginal Mesh
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pelvic Organ Prolapse Devices Market Size Forecast by Applications
12.10.1 Mild Pelvic Organ Prolapse
12.10.2 Stress Urinary Incontinence
12.10.3 Severe Pelvic Organ Prolapse
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pelvic Organ Prolapse Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pelvic Organ Prolapse Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pelvic Organ Prolapse Devices Market Size Forecast by Type
13.6.1 Vaginal Pessary
13.6.2 Vaginal Mesh
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pelvic Organ Prolapse Devices Market Size Forecast by Applications
13.10.1 Mild Pelvic Organ Prolapse
13.10.2 Stress Urinary Incontinence
13.10.3 Severe Pelvic Organ Prolapse
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pelvic Organ Prolapse Devices Market: Competitive Dashboard
14.2 Global Pelvic Organ Prolapse Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 CooperSurgical
14.3.2 MedGyn
14.3.3 Personal Medical Corp
14.3.4 Integra LifeSciences
14.3.5 Panpac Medical
14.3.6 Medesign
14.3.7 Smiths Medical
14.3.8 Thomas Medical
14.3.9 Kangge Medical
14.3.10 Dr. Arabin
14.3.11 CooperSurgical
